HomeNAMS • NASDAQ
add
NewAmsterdam Pharma Company NV
Previous close
$24.95
Day range
$24.13 - $25.28
Year range
$15.19 - $27.29
Market cap
2.63B USD
Avg Volume
1.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 29.11M | 889.83% |
Operating expense | 54.11M | 3.08% |
Net income | -16.65M | 64.68% |
Net profit margin | -57.18 | 96.43% |
Earnings per share | -0.16 | — |
EBITDA | -24.98M | 49.59% |
Effective tax rate | 0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 422.73M | 0.97% |
Total assets | 439.19M | — |
Total liabilities | 60.33M | — |
Total equity | 378.86M | — |
Shares outstanding | 92.39M | — |
Price to book | 6.07 | — |
Return on assets | -14.11% | — |
Return on capital | -16.29% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -16.65M | 64.68% |
Cash from operations | -12.50M | 73.39% |
Cash from investing | -75.00K | -733.33% |
Cash from financing | 58.00K | -68.82% |
Net change in cash | -7.98M | 83.51% |
Free cash flow | -12.24M | — |
About
Founded
2019
Website
Employees
62
